What are Analysts report about AMC Entertainment Holdings, Inc.(NYSE:AMC): REGENXBIO Inc.(NASDAQ:RGNX)

0
9

AMC Entertainment Holdings, Inc. (AMC) will report its next earnings on Feb 28 AMC. The company reported the earnings of $0.43/Share in the last quarter where the estimated EPS by analysts was $0.16/share. The difference between the expected and actual EPS was $0.27/share, which represents an Earnings surprise of 168.8%.

Many analysts are providing their Estimated Earnings analysis for AMC Entertainment Holdings, Inc. and for the current quarter 9 analysts have projected that the stock could give an Average Earnings estimate of $-0.26/share. These analysts have also projected a Low Estimate of $-0.54/share and a High Estimate of $-0.02/share.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for AMC Entertainment Holdings, Inc. as 1.25 Billion. According to these analysts, the Low Revenue Estimate for AMC Entertainment Holdings, Inc. is 1.18 Billion and the High Revenue Estimate is 1.32 Billion. The company had Year Ago Sales of 1.38 Billion.

Some buy side analysts are also providing their Analysis on AMC Entertainment Holdings, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for AMC Entertainment Holdings, Inc. might touch $23 high while the Average Price Target and Low price Target is $19.58 and $15 respectively.

AMC Entertainment Holdings, Inc. closed its last trading session at $14.43 with the gain of 0.35%. The Market Capitalization of the company stands at 1.51 Billion. The Company has 52-week high of $20.70 and 52-week low of $11.66. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.34% where SMA50 and SMA200 are 3.22% and -7.88% respectively. The Company Touched its 52-Week High on 09/21/18 and 52-Week Low on 12/27/18.

The Relative Volume of the company is 0.77 and Average Volume (3 months) is 1.42 million. The company’s P/E (price to earnings) ratio is 20.57 and Forward P/E ratio of 52.65.

The company shows its Return on Assets (ROA) value of 1.2%. The Return on Equity (ROE) value stands at 6.6%. While it’s Return on Investment (ROI) value is 3.7%.

While looking at the Stock’s Performance, AMC Entertainment Holdings, Inc. currently shows a Weekly Performance of -2.16%, where Monthly Performance is 9.2%, Quarterly performance is -4.23%, 6 Months performance is -21.14% and yearly performance percentage is 5.85%. Year to Date performance value (YTD perf) value is 17.92%. The Stock currently has a Weekly Volatility of 3.04% and Monthly Volatility of 4.18%.

REGENXBIO Inc. (RGNX) will report its next earnings on Feb 27 AMC. The company reported the earnings of $0.11/Share in the last quarter where the estimated EPS by analysts was $-0.34/share. The difference between the expected and actual EPS was $0.45/share, which represents an Earnings surprise of 132.4%.

Many analysts are providing their Estimated Earnings analysis for REGENXBIO Inc. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $-0.84/share. These analysts have also projected a Low Estimate of $-0.91/share and a High Estimate of $-0.79/share.

Some buy side analysts are also providing their Analysis on REGENXBIO Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for REGENXBIO Inc. might touch $127.5 high while the Average Price Target and Low price Target is $81.5 and $41 respectively.

REGENXBIO Inc. closed its last trading session at $57.79 with the loss of -5.71%. The Market Capitalization of the company stands at 2.03 Billion. The Company has 52-week high of $85.10 and 52-week low of $26.80. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.93% where SMA50 and SMA200 are 14.94% and -9.73% respectively. The Company Touched its 52-Week High on 07/10/18 and 52-Week Low on 04/06/18.

The Relative Volume of the company is 1.03 and Average Volume (3 months) is 555.9 million. The company’s P/E (price to earnings) ratio is 18.87 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 23.3%. The Return on Equity (ROE) value stands at 24.7%. While it’s Return on Investment (ROI) value is 16.3%.

While looking at the Stock’s Performance, REGENXBIO Inc. currently shows a Weekly Performance of -1.39%, where Monthly Performance is 15.69%, Quarterly performance is 1.98%, 6 Months performance is -26.66% and yearly performance percentage is 64.87%. Year to Date performance value (YTD perf) value is 29.89%. The Stock currently has a Weekly Volatility of 4.17% and Monthly Volatility of 5.66%.

SHARE